Sinopharm Group CoSHTDF -2.67%78 Median PS Value is $3.56 as of Jun. 24, 2026, which is 790% above its 10-year median of 0.40. GuruFocus rates SHTDF with a GF Score™ of 78/100 and a GF Value™ of $3.03 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 70 Medical Distribution companies, Sinopharm Group Co ranks better than 60% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Sinopharm Group Co's Median PS Value or its related term are showing as below:
SHTDF'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.28 Med: 0.4 Max: 0.79
Current: 0.64
During the past 13 years, the highest Price to Median PS Value of Sinopharm Group Co was 0.79. The lowest was 0.28. And the median was 0.40.
SHTDF's Price-to-Median-PS-Value is ranked better than 60% of 70
companies
in the Medical Distribution industry
Industry Median: 0.79
vs SHTDF: 0.64
Sinopharm Group Co (OTCPK:SHTDF) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Sinopharm Group Co's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
2.2872
/
3.56
=
0.64
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinopharm Group Co Median PS Value Related Terms
Sinopharm Group Co Median PS Value Historical Data
* Premium members only.
The historical data trend for Sinopharm Group Co's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHTDF vs MCK, COR, CAH: Median PS Value Comparison
For the Medical Distribution subindustry, Sinopharm Group Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinopharm Group Co Price-to-Median-PS-Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sinopharm Group Co's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Sinopharm Group Co's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.1373.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sinopharm Group Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $25.92.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinopharm Group Co (SHTDF) has a Median PS Value of $3.56 as of Jun. 24, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Sinopharm Group Co and its competitors. This is 790% above median its historical median of 0.40. Over the past decade, Sinopharm Group Co's Median PS Value has ranged from 0.28 to 0.79. According to the industry distribution chart, Sinopharm Group Co ranks #28 out of 70 companies in the Medical Distribution industry, placing it in the top 40%.
Is Sinopharm Group Co's Median PS Value too high?
Sinopharm Group Co's current Median PS Value of $3.56 is 790% above median its 10-year median of 0.40. Over the past 10 years, this metric has ranged from a low of 0.28 to a high of 0.79. The Medical Distribution industry median Median PS Value is 0.79. Sinopharm Group Co's value of $3.56 is 350.6% above this industry median. Based on the distribution chart, Sinopharm Group Co ranks #28 out of 70 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Sinopharm Group Co has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sinopharm Group Co's Median PS Value compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Sinopharm Group Co ranks #28 out of 70 companies for Median PS Value. This puts Sinopharm Group Co in the upper half of its industry. The industry median Median PS Value is 0.79. Sinopharm Group Co's value of $3.56 is 350.6% above this benchmark. Historically, Sinopharm Group Co's own Median PS Value has ranged from 0.28 to 0.79 over the past decade. While the company's 10-year median is 0.40 vs. the industry median of 0.79, Sinopharm Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Distribution company?
The median Median PS Value among Medical Distribution companies is 0.79, based on 70 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sinopharm Group Co's current Median PS Value of $3.56 is 350.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Sinopharm Group Co and its competitors. For the Medical Distribution industry, the median Median PS Value is 0.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sinopharm Group Co's current Median PS Value is $3.56, which is 790% above median its own 10-year median of 0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinopharm Group Co stock overvalued right now?
Based on GuruFocus' analysis, Sinopharm Group Co (SHTDF) is currently considered Modestly Undervalued. The stock's GF Value™ is $3.03, compared to a current price of $2.29 — trading 24.5% below its estimated fair value. The current Median PS Value is $3.56, which is 790% above median its 10-year median of 0.40 and 350.6% above the Medical Distribution industry median of 0.79. Sinopharm Group Co's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Sinopharm Group Co (SHTDF), the current Median PS Value is $3.56 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sinopharm Group Co (SHTDF) Overvalued in 2026?
Based on GuruFocus' analysis, Sinopharm Group Co stock appears to be undervalued.
The current stock price of $2.29 is trading 24.5% below its estimated GF Value™ of $3.03.
GuruFocus considers Sinopharm Group Co to be Modestly Undervalued.
Key valuation signals for SHTDF:
Median PS Value: $3.56 (790% above median its 10-year median of 0.40)
GF Value™: $3.03 vs. price of $2.29 (24.5% below fair value)
Industry Position: 350.6% above the Medical Distribution median (#28 of 70)
No single metric tells the full story. See the SHTDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2024. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.
78GF Score
Get the complete analysis for SHTDF
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHTDF has been successfully added to your 
